Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Oncotarget|February 10, 2018
Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical settingAnnacarmen Petrizzo, Angela Mauriello, Antonio Luciano, et al.
Cancers|July 27, 2022
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A ReviewFrancesco Perri, Giuseppina Della Vittoria Scarpati, Monica Pontone, et al.
Pharmaceutics|June 2, 2021
Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer CenterMichela Piezzo, Roberta D'Aniello, Ilaria Avallone, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 19, 2023
High levels of PD-L1 on platelets of NSCLC patients contributes to the pharmacological activity of AtezolizumabChiara Colarusso, Anna Falanga, Michela Terlizzi, et al.
In Vivo (Athens, Greece)|April 24, 2016
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical ResearchDomenica Rea, Carmela Coppola, Antonio Barbieri, et al.
Journal of Clinical Medicine|May 28, 2022
Electrochemotherapy of Primary Colon Rectum Cancer and Local Recurrence: Case Report and Prospective AnalysisDaniela Rega, Vincenza Granata, Antonella Petrillo, et al.
Oncology|January 6, 2016
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant ChemotherapyAlessandro Ottaiano, Anna Nappi, Salvatore Tafuto, et al.
BMC Health Services Research|November 27, 2020
Clinical trials and drug cost savings for Italian health serviceFrancesca D'Ambrosio, Gianfranco De Feo, Gerardo Botti, et al.
Cancers|July 2, 2021
Organ Sparing for Locally Advanced Rectal Cancer after Neoadjuvant Treatment Followed by ElectrochemotherapyDaniela Rega, Vincenza Granata, Antonella Petrillo, et al.
Frontiers in Pharmacology|September 16, 2016
Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"Sabrina C Cecere, Sabrina Rossetti, Carla Cavaliere, et al.
Pageof 6